BLRD Research Career Scientist Award Application
BLRD Research Career Scientist Award Application
批准号:
10589966
负责人:
Shuk-Mei Ho
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-10-01 至 2027-09-30
关键词:
AccountingAddressAdsorptionAdultAfghanistanAgarAndrogen SuppressionAnimal ModelAnimalsAnniversaryAromatic Polycyclic HydrocarbonsArsenicAwardBarker HypothesisBiological MarkersBody FluidsCanadaCancer PatientCancer Research ProjectCarcinogensCell DeathCell SeparationCellsCensusesChemicalsChildhood AsthmaChronic DiseaseClassificationClinical ResearchCommunitiesDataDatabasesDepartment of DefenseDermalDevelopmentDiagnosticDiseaseDisparityDrug TargetingESR1 geneEducational workshopElderlyEndocrine DisruptorsEndocrine disruptionEnvironmentEnvironmental ExposureEnvironmental HealthEnvironmental and Occupational ExposureEpidemiologyEpigenetic ProcessEpitheliumEstrogen Receptor betaEstrogensEuropean UnionExposure toFundingGPER geneGeneral PopulationGenesGenetic TranscriptionGoalsGonadal Steroid HormonesGrantHealthHigh-Risk CancerHormonal CarcinogenesisHumanImmuneIncidenceInfluentialsInformaticsIngestionInhalationInternationalInternational AgenciesInterventionIonsIraqJointsKidney TransplantationKnowledgeLeadLead levelsLesionLifeLinkMalignant NeoplasmsMalignant neoplasm of prostateMediatingMedical ResearchMetal CarcinogenesisMetal exposureMetalsMethylationMilitary PersonnelMolecularMusNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Environmental Health SciencesNational Toxicology ProgramOccupationalOccupational ExposureOccupationsOhioOilsOncogenicPaperParticipantPeer ReviewPoliciesPopulationProductivityProstateProstatic EpitheliumProtein IsoformsPublishingRefuse DisposalReportingResearchRiskRisk FactorsRoleSafetyScientistSeminalSignal PathwaySmokeSocietiesSourceStrategic PlanningTestingThe Cancer Genome AtlasTherapeuticToxicant exposureToxicologyTranslatingTranslationsTumor Suppressor ProteinsUmbilical Cord BloodUnited StatesUnited States Department of Veterans AffairsUnited States National Institutes of HealthUrineUrologyVeteransVisualizationWomanWorkage groupanticancer researchbisphenol Aburn pitcancer diagnosiscancer stem cellcarcinogenesiscarcinogenicitycareercastration resistant prostate cancerchemical carcinogencomparison controlconsumer behaviordata registrydisabilitydisorder riskearly life exposureenvironmental toxicologyepigenomicsepithelial stem cellexperiencegenetic signaturehazardhigh riskhormone regulationimprovedin vivoindexinginsightlead exposuremalemembermetaplastic cell transformationmilitary servicemilitary veteranmouse modelneoplasm registrynovelnovel strategiesprecision medicinepremalignantpreventprogramspromoterprostate cancer cellprostate cancer modelprostate cancer preventionprostate cancer riskprostate carcinogenesispublic health interventionpublic health researchsingle-cell RNA sequencingspecific biomarkersstem cell biologystem cell populationstem cellsstem-like cellsymposiumtoxicanttranscriptomicstrendunderstudied cancerurinaryurologic
中文摘要
点击翻译按钮获取中文摘要
英文摘要
According to the United States (US) Census Bureau, the number of veterans in the US in 2018 was around 19.9
million. Nine out of 10 were males, and 33% were between 50-69 years old, an age group that is at the highest
risk for prostate cancer (PCa). The VA Central Cancer Registry consistently shows that PCa is the most
frequently diagnosed cancers among male veterans, accounting for >30% of the approximately 50,000 cancer
diagnoses. There is growing concern that environmental and/or occupational exposure to metal ions during
deployment and post-deployment increases PCa risk in veterans. The International Agency for Cancer Research
classified inorganic arsenic (iAs) as a carcinogen, while lead (Pb) is a potential carcinogen in humans. Pb
exposure is a known hazard of military service, while data for iAs exposure is less well-established. Further,
wide-spread exposure to these metal ions in veterans could be mediated through inhalation, ingestion, and
dermal adsorption of toxic smoke from burning oil fields and waste disposal burn-pits. iAs and/or Pb exposure
have been considered potential risk factors for PCa, but the underlying mechanism is largely undefined. In a
small clinical study, we found that iAs and Pb levels were significantly higher in the urine of PCa patients
compared to controls. Using our new 2-hit animal model, we found that exposure to iAs or Pb increased (1) PCa
risk in vivo and (2) the ability of prostate epithelial stem-like cells (PrESLCs) isolated from treated animals to
form colonies in soft agar, a hallmark of cellular transformation. In this animal model, a 1-month metal treatment
followed by chemical carcinogen treatment significantly increased the incidence of PCa and pre-cancerous
lesions in iAs-treated mice, with similar trends in Pb-treated animals. Importantly, single-cell RNAseq analyses
revealed that Pb was associated with the expansion of a subpopulation of PrESLCs with epithelial lineage
markers into stroma-like oncogenic cells, while iAs was associated with the emergence of a rare, unique
subpopulation of oncogenic PrESLCs similar to “cancer” stem cells. This proposal will test the hypothesis that
iAs and/or Pb dysregulate specific, and likely different, signaling pathways in subpopulations of
PrESLCs to initiate or increase the risk of carcinogenesis in the prostate. This is an untested hypothesis
in the field of prostate carcinogenesis and in military veterans’ health. Two Aims are proposed. Aim 1: Determine
the carcinogenic potential of metal treated PrESLCs in vivo using a renal grafting model of PCa formation. We
will evaluate the effects of metals on the formation of PCa in vivo in immune-deficient host mice, either with or
without chemical induction of PCa. Aim 2: Characterize stem-like cells with metal-specific transcriptomic
signatures. We will use single-cell RNAseq and visualization informatics to identify the unique gene signatures
that characterize rare subpopulations of metal-induced cancer stem cells within the PrESLC population. We aim
to apply these gene signatures to enrich rare subpopulations by FACS and evaluate their carcinogenic potential.
We will also leverage The Cancer Genome Atlas PCa data and other online databases to enable accurate
classification of major, rare, and heterogeneous subtypes of PrESLCs to gain insights into metal carcinogenesis.
Findings from the proposed work may address questions related to occupational and post-deployment exposure
and expand our knowledge of stem cell biology. Successful completion of these studies may lead to the
development of new PCa prevention and therapeutic strategies. Plans to reduce unnecessary exposure to those
metal ions can be justified and implemented as effective strategies for PCa prevention. Drugs targeting specific
subpopulations of stem cells may be used as therapeutic options to prevent early PCa development and slow
progression. When applied to veterans, the results of this study may save lives, improve health, and decrease
disabilities in this community and beyond.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RNA modifications by paternal exposure to arsenic and intergenerational effects on sperm quality
-
批准号:10391233
-
项目类别:
-
资助金额:$49.52万
-
财政年份:2022
-
负责人:Shuk-Mei Ho
-
依托单位:
RNA modifications by paternal exposure to arsenic and intergenerational effects on sperm quality
-
批准号:10615715
-
项目类别:
-
资助金额:$49.96万
-
财政年份:2022
-
负责人:Shuk-Mei Ho
-
依托单位:
Metal-induced cell-level changes in prostate epithelium and cancer risk
-
批准号:10382227
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:Shuk-Mei Ho
-
依托单位:
Metal-induced cell-level changes in prostate epithelium and cancer risk
-
批准号:10664831
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:Shuk-Mei Ho
-
依托单位:
Effects of Arsenic on Human Prostate Stem Cells and Prostate Cancer Risk
-
批准号:8535765
-
项目类别:
-
资助金额:$35.44万
-
财政年份:2012
-
负责人:Shuk-Mei Ho
-
依托单位:
Effects of Arsenic on Human Prostate Stem Cells and Prostate Cancer Risk
-
批准号:8390359
-
项目类别:
-
资助金额:$38.71万
-
财政年份:2012
-
负责人:Shuk-Mei Ho
-
依托单位:
Effects of Arsenic on Human Prostate Stem Cells and Prostate Cancer Risk
-
批准号:9058540
-
项目类别:
-
资助金额:$40.55万
-
财政年份:2012
-
负责人:Shuk-Mei Ho
-
依托单位:
Effects of Arsenic on Human Prostate Stem Cells and Prostate Cancer Risk
-
批准号:8664850
-
项目类别:
-
资助金额:$36.87万
-
财政年份:2012
-
负责人:Shuk-Mei Ho
-
依托单位:
Chronic exposure to Biphenol A and uterine cancer risk markers
-
批准号:8686853
-
项目类别:
-
资助金额:$27.2万
-
财政年份:2011
-
负责人:Shuk-Mei Ho
-
依托单位:
G-protein coupled receptor-30(GPR30):a putative new therapeutic target for PCa
-
批准号:8044909
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Shuk-Mei Ho
-
依托单位:
Chronic exposure to Biphenol A and uterine cancer risk markers
-
批准号:8334566
-
项目类别:
-
资助金额:$17.91万
-
财政年份:2011
-
负责人:Shuk-Mei Ho
-
依托单位:
G-protein coupled receptor-30(GPR30):a putative new therapeutic target for PCa
-
批准号:8253504
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Shuk-Mei Ho
-
依托单位:
G-protein coupled receptor-30(GPR30):a putative new therapeutic target for PCa
-
批准号:8397551
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Shuk-Mei Ho
-
依托单位:
Chronic exposure to Biphenol A and uterine cancer risk markers
-
批准号:8477195
-
项目类别:
-
资助金额:$27.67万
-
财政年份:2011
-
负责人:Shuk-Mei Ho
-
依托单位:
Chronic exposure to Biphenol A and uterine cancer risk markers
-
批准号:8232563
-
项目类别:
-
资助金额:$6.84万
-
财政年份:2011
-
负责人:Shuk-Mei Ho
-
依托单位:
Kettering Lab Renovation to enhance PHS-supported environmental health research
-
批准号:7839524
-
项目类别:
-
资助金额:$481.95万
-
财政年份:2010
-
负责人:Shuk-Mei Ho
-
依托单位:
Susceptible Window of High Fat Diet/Bisphenol A Programming of Breast Cancer Risk
-
批准号:8146132
-
项目类别:
-
资助金额:$43.04万
-
财政年份:2010
-
负责人:Shuk-Mei Ho
-
依托单位:
Administrative Core
-
批准号:8054350
-
项目类别:
-
资助金额:$58.96万
-
财政年份:2010
-
负责人:Shuk-Mei Ho
-
依托单位:
Susceptible Window of High Fat Diet/Bisphenol A Programming of Breast Cancer Risk
-
批准号:8490704
-
项目类别:
-
资助金额:$40.21万
-
财政年份:2010
-
负责人:Shuk-Mei Ho
-
依托单位:
Susceptible Window of High Fat Diet/Bisphenol A Programming of Breast Cancer Risk
-
批准号:8539124
-
项目类别:
-
资助金额:$7.81万
-
财政年份:2010
-
负责人:Shuk-Mei Ho
-
依托单位:
海外基金